24小时热门版块排行榜    

查看: 223  |  回复: 0

yzhuang

金虫 (小有名气)

[交流] 【交流】纽约时报有关中国制药行业现状的描述

摘录出最后三段。全文见:
http://www.nytimes.com/2010/07/0 ... ;_r=1&ref=world

龙象之争真的是无处不在。不过,印度人总是善于让自己的声音被世界所听到!商场如战场,对敌人仁慈等于对自己残忍。他们是深谙此道的。

The F.D.A. has issued about 900 approvals to plants in India to import drugs or raw materials for the industry to the United States, the vast majority in recent years, compared with more than 300 such approvals for China.

Indian companies have “a lot to offer and the cost advantage is huge,” said Swetha Shantikumar, a research analyst in Chennai with Frost & Sullivan, who predicted more buyouts of Indian firms by global giants in the near future. Chinese firms “don’t have the technical capacity to produce sophisticated drugs,” said Ms. Shantikumar.

“If you want to make simpler drugs like aspirin,” she said, “you manufacture them in China.”
回复此楼

» 猜你喜欢

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

智能机器人

Robot (super robot)

我们都爱小木虫

相关版块跳转 我要订阅楼主 yzhuang 的主题更新
普通表情 高级回复 (可上传附件)
信息提示
请填处理意见